The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Leveraging innate immunity with AFM24, a novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager: Interim results for the non-small cell lung cancer (NSCLC) cohort.
 
Anthony B. El-Khoueiry
Honoraria - ABL bio; Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; EISAI; EMD Serono; Exelixis; Gilead Sciences; Merck; QED Therapeutics; Qurient; Roche/Genentech; Senti Biosciences; SERVIER; Tallac Therapeutics
Consulting or Advisory Role - ABL Bio; Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; QED Therapeutics; Qurient; Roche; Senti Biosciences; SERVIER; Tallac Therapeutics
Research Funding - Astex Pharmaceuticals; AstraZeneca; Fulgent Genetics
 
Delcia Rivas
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Se-Hoon Lee
Honoraria - Amgen; AstraZeneca/MedImmune; Lilly; Merck; Roche
Consulting or Advisory Role - AstraZeneca; BMS/Ono; IMBdx; Janssen; Lilly; Merck; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Lunit; Merck
Travel, Accommodations, Expenses - Novartis
 
Jacob Stephen Thomas
No Relationships to Disclose
 
Yu Jung Kim
No Relationships to Disclose
 
Andres Cervantes
Consulting or Advisory Role - Amgen (Inst); Foundation Medicine (Inst); Merck Serono (Inst); Roche (Inst); Transgene (Inst)
Research Funding - Actuate Therapeutics (Inst); Adaptimmune (Inst); Amcure (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca Spain (Inst); Bayer (Inst); BeiGene (Inst); BMSi (Inst); FibroGen (Inst); Genentech (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Natera (Inst); Novartis (Inst); SERVIER (Inst); Sierra Oncology (Inst); Takeda (Inst)
Other Relationship - Annals of Oncology; Cancer Treatment Reviews; ESMO Open
 
Omar Saavedra
No Relationships to Disclose
 
Byoung Yong Shim
Consulting or Advisory Role - AstraZeneca; Bion; Guardant Health; J Ints Bio; Pfizer; Takeda
Research Funding - Yuhan
 
Laura Kohlhas
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Gabriele Hintzen
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics; Novartis
 
Michael Emig
Employment - Affimed Therapeutics; Lilly; Merck KGaA
Stock and Other Ownership Interests - Lilly
 
Pilar Nava-Parada
Employment - Affimed Therapeutics; Pfizer
Stock and Other Ownership Interests - Abbvie; Actinium Pharmaceuticals; Adaptive Biotechnologies; Affimed Therapeutics; BeyondSpring Pharmaceuticals; BioNTech; Bristol-Myers Squibb; Celularity; Gilead Sciences; Metlife Insurance; Moleculin Biotech; Pfizer; Quest Diagnostics; Vaxart; Viatris